2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow MD1003: new trials by email Literature Review of MD1003 trials Research Report on MD1003
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy Subjects MD1003 - Healthy Volunteers, Hepatic Impairment of Moderate Child Pugh Category | Phase 1 | Terminated | MedDay Pharmaceuticals SA | 15 | 2019-10-11 | 2020-05-13 |
| RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects MD1003 - Healthy Volunteers, Impaired Renal Function | Phase 1 | Terminated | MedDay Pharmaceuticals SA | 24 | 2019-10-09 | 2020-05-13 |
France (2) · Hungary (2)
2019 (2)